FTC: Delays in generic drugs on the rise
(AP)


AP - Drug companies increasingly are reaching legal settlements that delay the introduction of cheaper generic medicines and cheat Americans of billions of dollars a year in savings, federal regulators on Wednesday told lawmakers seeking to ban the agreements.